This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The university has backtracked on its plan to raise tuition by up to 7% and withdraw a promise to freeze tuition, after lawmakers kept the university’s funding largely intact.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The Oregon Health Authority awarded $6 million to Oregon Health & Science University for a plan that was hastily put together and then scrapped; now it's banking on a $1.2 million project by Oregon State University.
An infected staff member had contact with a lot of patients in an office lax about face coverings, prompting an unusual health alert.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
In response to blistering criticism from Black employees, OHSU's president and chief of diversity say they will hire a consultant to root out any racism in hiring and the affirmative action department.
The suit says the Doernbecher Children's Hospital hire was fired after calling out unsafe practices, being stereotyped as an "angry Black woman" and told to "straighten her hair."
Read the latest corporate and governmental news from around the Northwest.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
An employee resource group accuses administrators of taking no substantial action following several noose incidents and using them in what they say is a sham of an effort against racism on campus.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The abortion rights group has a new leader, Christel Allen, the first woman of color to lead the group. Allen, in turn, chose Jeanine Morales, a Black woman with experience advocating for minorities, as her deputy.
The nonprofit will be testing a new drug developed by Pfizer and BioNTech that produced a strong immune response in early trials.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
The two sides meet again on Wednesday after two years of failing to reach an agreement. Wages remain the chief sticking point.
